Organisations should adopt shared platforms and automated governance to keep pace with the growing use of generative AI tools ...
The Boston startup uses AI to translate and verify legacy software for defense contractors, arguing modernization can’t come at the cost of new bugs.
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results